{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-04-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Pine Brook",
      "state": "NJ",
      "country": "United States",
      "classification": "Class III",
      "openfda": {},
      "product_type": "Drugs",
      "event_id": "76664",
      "recalling_firm": "Alvogen, Inc",
      "address_1": "10 Bloomfield Ave Bldg B Ste 2",
      "address_2": "N/A",
      "postal_code": "07058-9743",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0628-2017",
      "product_description": "Adalat CC (nifedipine) Extended Release Tablets 30 mg, 100-count bottles, Rx only,  Manufactured for Bayer Healthcare Bayer Healthcare Pharmaceuticals Inc. Whippany, NJ 07901 Manufactured in Germany, NDC 50419-701-05",
      "product_quantity": "N/A",
      "reason_for_recall": "Cross Contamination with another product:residual powder found in inlet air duct identified as sorafenib",
      "recall_initiation_date": "20170307",
      "center_classification_date": "20170404",
      "termination_date": "20171215",
      "report_date": "20170412",
      "code_info": "Lot #: BXH1P21A, Exp. 11/2017"
    }
  ]
}